Glaxo Smith Kline (GSK)
GlaxoSmithkline has two manufacturing facilities in Singapore, located in Quality Road and Jurong, supplying Active Pharmaceutical Ingredients (APIs) in 16 products for the global markets. Jurong is also home to an R&D Chemical Development Pilot Plant which produces APIs in their final phase of development.
The APIs manufactured in Singapore are used in products for the treatment of flu, asthma, HIV, cancer, ulcers and pain management.
Mr Yeo Yee Pang attended the SCEM training programme and is a certified SCEM. He is the key person responsible for energy management at GlaxoSmithkline (Glaxo Wellcome Manufacturing). Together with an energy management committee lead by Mr Yeo, yearly targets for energy savings are set. The Committee also identifies energy saving projects to be carried out. Since 2002, he had worked with the team to identify energy wastage in many areas within the site and also introduced the use of a monitoring and targeting systems that has provided the site with a better understanding of its energy usage.
The monitoring and targeting system goes a long way towards helping the energy management committee to single out projects that promise to pay off where energy savings are concerned.
In 2011, GSK signed up to the UN Caring for Climate initiative, reflecting the commitment to take action on climate change.
GSK has implemented close to 300 energy saving projects and achieved savings in excess of $12.5 million.